Latest News about BMY
Recent news which mentions BMY
From Benzinga
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
January 04, 2025
From Motley Fool
From Benzinga
Peering Into Bristol-Myers Squibb's Recent Short Interest
December 31, 2024
Tickers
BMY
From Benzinga
2 High-Yield Dividend Stocks to Buy Early in 2025
December 31, 2024
From Motley Fool
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
December 23, 2024
From Benzinga
From Motley Fool
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
December 22, 2024
From Benzinga
Want Decades of Passive Income? 3 Stocks to Buy Right Now
December 21, 2024
From Motley Fool
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
December 19, 2024
From Benzinga
From Motley Fool
Got $250? 2 Healthcare Stocks to Buy and Hold Forever
December 19, 2024
From Motley Fool
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?
December 19, 2024
From Motley Fool
From Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
December 17, 2024
From Benzinga
Bristol-Myers Squibb Shares Rise After Analyst Upgrades, Positive Pipeline Outlook
December 16, 2024
From Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
December 16, 2024
From Benzinga
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
December 16, 2024
From Benzinga
From Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
December 03, 2024
From Benzinga
Why Is Purple Biotech Stock Trading Higher On Monday?
December 02, 2024
From Benzinga
Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program
November 29, 2024
From Benzinga
3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold Forever
November 29, 2024
From Motley Fool
From Motley Fool
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
November 18, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.